Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice

G. A. Filice; C. Pomeroy

doi:10.1128/AAC.35.4.780

Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice

G. A. Filice, C. Pomeroy

Medicine - Veteran's Administration Medical Center

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Clindamycin was used to treat the reactivation of a chronic Toxoplasma gondii infection in mice. Clindamycin reduced mortality by 44% when used prophylactically (P < 0.001) but appeared to be less effective when used to treat clinically apparent reactivation. Further studies should be conducted to establish the efficacy of clindamycin for the treatment of toxoplasmosis in humans.

Original language	English (US)
Pages (from-to)	780-782
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	35
Issue number	4
DOIs	https://doi.org/10.1128/AAC.35.4.780
State	Published - 1991

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1128/AAC.35.4.780

OpenUrl availability

Full text

Cite this

@article{b90ecd73bcfe4c4aaf4bc6dcfe52a0c2,

title = "Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice",

abstract = "Clindamycin was used to treat the reactivation of a chronic Toxoplasma gondii infection in mice. Clindamycin reduced mortality by 44% when used prophylactically (P < 0.001) but appeared to be less effective when used to treat clinically apparent reactivation. Further studies should be conducted to establish the efficacy of clindamycin for the treatment of toxoplasmosis in humans.",

author = "Filice, {G. A.} and C. Pomeroy",

year = "1991",

doi = "10.1128/AAC.35.4.780",

language = "English (US)",

volume = "35",

pages = "780--782",

journal = "Antimicrobial agents and chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "4",

}

TY - JOUR

T1 - Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice

AU - Filice, G. A.

AU - Pomeroy, C.

PY - 1991

Y1 - 1991

N2 - Clindamycin was used to treat the reactivation of a chronic Toxoplasma gondii infection in mice. Clindamycin reduced mortality by 44% when used prophylactically (P < 0.001) but appeared to be less effective when used to treat clinically apparent reactivation. Further studies should be conducted to establish the efficacy of clindamycin for the treatment of toxoplasmosis in humans.

AB - Clindamycin was used to treat the reactivation of a chronic Toxoplasma gondii infection in mice. Clindamycin reduced mortality by 44% when used prophylactically (P < 0.001) but appeared to be less effective when used to treat clinically apparent reactivation. Further studies should be conducted to establish the efficacy of clindamycin for the treatment of toxoplasmosis in humans.

UR - http://www.scopus.com/inward/record.url?scp=0025767766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025767766&partnerID=8YFLogxK

U2 - 10.1128/AAC.35.4.780

DO - 10.1128/AAC.35.4.780

M3 - Article

C2 - 2069389

AN - SCOPUS:0025767766

SN - 0066-4804

VL - 35

SP - 780

EP - 782

JO - Antimicrobial agents and chemotherapy

JF - Antimicrobial agents and chemotherapy

IS - 4

ER -

Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice

Abstract

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this